Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KANINE: Ketamine Sedation in the ICU
NCT06767358Phase 3Recruiting
- Sponsor
- McMaster University
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in critical illness, sponsored by McMaster University. Started Nov 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT06767358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06767358.